High Cholesterol / Heart Disease Study
The MK0616-05 clinical study will test an oral investigational drug to see if it may safely and effectively lower the risk of major adverse cardiovascular events, such as a heart attack, a stroke, or heart disease in participants at high cardiovascular risk.
Despite the availability of LDL-C lowering therapies to help lower cholesterol, many people still struggle to reach their target cholesterol levels. High cholesterol, if left untreated, can lead to a type of heart disease called atherosclerotic cardiovascular disease, which increases the risk of cardiovascular events such as heart attack or stroke.
Currently available treatments are effective tools to treat high cholesterol but some must be provided by a doctor by injection and can be hard for people to access.
A clinical study is underway at our Woodstock location to evaluate the safety and efficacy of an investigational once-daily oral PCSK9 inhibitor to see whether it may lower LDL-C.
You may qualify if you:
- Have high cholesterol.
- Have had, or are at risk of having, a serious health incident related to your high cholesterol (such as heart attack, stroke, or heart disease) or procedure to reopen a blocked artery in your neck or legs.
- Are over the age of 50 and at high risk for a cardiovascular event.
- Currently take medication for high cholesterol.
- Are over the age of 60 and have risk factors such as diabetes mellitus or high blood pressure.
You may receive study medication at no cost and your time and travel may be compensated if you qualify.
Find Out if You Qualify
Please fill out the form to see if you qualify. We’ll contact you directly to inquire about your eligibility for this research study.
* Field not required
